posted on 2020-04-27, 12:36authored byOksana Dmytriyeva, Amaia de Diego Ajenjo, Kathrine Lundø, Henrik Hertz, Kim K. Rasmussen, Anders T. Christiansen, Jorg Klingelhofer, Alexander L. Nielsen, Jan Hoeber, Elena Kozlova, David P. D. Woldbye, Stanislava Pankratova
Vascular
endothelial growth factor B (VEGFB) is a pleiotropic trophic
factor, which in contrast to the closely related VEGFA is known to
have a limited effect on angiogenesis. VEGFB improves survival in
various tissues including the nervous system, where the effect was
observed mainly for peripheral neurons. The neurotrophic effect of
VEGFB on central nervous system neurons has been less investigated.
Here we demonstrated that VEGFB promotes neurite outgrowth from primary
cerebellar granule, hippocampal, and retinal neurons in vitro. VEGFB protected hippocampal and retinal neurons from both oxidative
stress and glutamate-induced neuronal death. The VEGF receptor 1 (VEGFR1)
is required for VEGFB-induced neurotrophic and neuroprotective effects.
Using a structure-based approach, we designed short peptides, termed
Vefin1–7, mimicking the binding interface of VEGFB to VEGFR1.
Vefins were analyzed for their secondary structure and binding to
VEGF receptors and compared with previously described peptides derived
from VEGFA, another ligand of VEGFR1. We show that Vefins have neurotrophic
and neuroprotective effects on primary hippocampal, cerebellar granule,
and retinal neurons in vitro with potencies comparable
to VEGFB. Similar to VEGFB, Vefins were not mitogenic for MCF-7 cancer
cells. Furthermore, one of the peptides, Vefin7, even dose-dependently
inhibited the proliferation of MCF-7 cells in vitro. Unraveling the neurotrophic and neuroprotective potentials of VEGFB,
the only nonangiogenic factor of the VEGF family, is promising for
the development of neuroprotective peptide-based therapies.